- Cerulean Pharma Inc CERU shares dipped 61.5 percent to $1.28. Cerulean Pharma and Daré Bioscience reported that they have entered into a stock purchase agreement. Cerulean also announced plans to reduce workforce by 11 people. The company reported that it has sold CRLX101 and CRLX301 to BlueLink Pharmaceuticals for $1.5 million and also agreed to sell Dynamic Tumor Targeting Platform to Novartis for $6 million.
- Medgenics Inc GNMX shares tumbled 55 percent to $2.45 after the company disclosed that that SAGA trial of AEVI-001 did not meet primary endpoint.
- TOP SHIPS Inc TOPS shares dropped 22.3 percent to $1.53 after declining 10.45 percent on Friday.
- DryShips Inc. DRYS shares fell 18 percent to $1.37. On Friday, DryShips reported the successful completion of the $200.0 million common stock offering.
- Ritter Pharmaceuticals Inc RTTR shares declined 15 percent to $1.92.
- Trans World Entertainment Corporation TWMC shares dropped 11.7 percent to $2.08.
- QuickLogic Corporation QUIK shares fell 10.3 percent to $2.10. QuickLogic reported a $15 million share offering.
- Pulmatrix Inc PULM shares declined 10 percent to $2.78 after the company reported up to $11 million at-the-market sales agreement with BTIG on Friday.
- Agile Therapeutics Inc AGRX shares dropped 6.1 percent to $2.76 after gaining 9.29 percent on Friday.
- Array Biopharma Inc ARRY slipped 5.6 percent to $9.97 after the company disclosed that it has withdrawn its NDA for Binimetinib.
- Caleres Inc CAL shares declined 4.5 percent to $26.69. Susquehanna downgraded Caleres from Positive to Neutral.
- Destination XL Group Inc DXLG shares fell 4.4 percent to $2.30. Destination XL Group reported Q4 earnings of $0.04 per share on revenue of $122.64 million. The company projects full-year loss of $0.14 per share to a loss of $0.06 per share, and revenue of $470 million to $480 million. Destination XL reported a $12 million buyback plan.
- Mechel PAO (ADR) MTL shares declined 4.4 percent to $5.21 after rising 11.45 percent on Friday.
- Bunge Ltd BG shares fell 3.4 percent to $79.07. Goldman Sachs downgraded Bunge from Buy to Neutral.
- Sonic Corporation SONC dropped 2.2 percent to $23.27. Canaccord Genuity downgraded Sonic from Buy to Hold.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in